World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
14771
World Ranking
11267
National Ranking
4881

Overview

David J. Sullivan is a researcher affiliated with Johns Hopkins University in the United States. Their work primarily spans the field of Medicine, with a focus on Infectious Diseases, Public Health, Environmental and Occupational Health, Molecular Biology, Neurology, and Obstetrics and Gynecology.

Their research topics have included SARS-CoV-2 and COVID-19 studies, COVID-19 clinical research, and long-term effects of COVID-19. Other notable areas of interest encompass malaria research and control, COVID-19 impacts on reproduction, SARS-CoV-2 detection and testing, and mosquito-borne diseases and control.

Frequent co-authors of David J. Sullivan include Arturo Casadevall, Evan M. Bloch, Shmuel Shoham, Aaron A.R. Tobian, and Andrew Pekosz.

Sullivan's publications have appeared notably in venues such as bioRxiv (Cold Spring Harbor Laboratory), mBio, Clinical Infectious Diseases, Transfusion, and the Journal of Clinical Investigation.

Selected recent papers authored or co-authored by Sullivan include:

  • Early Outpatient Treatment for Covid-19 with Convalescent Plasma, 2022, New England Journal of Medicine
  • Deployment of convalescent plasma for the prevention and treatment of COVID-19, 2020, Journal of Clinical Investigation
  • Survey of spiking in the mouse visual system reveals functional hierarchy, 2021, Nature
  • Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population, 2020, Journal of Clinical Investigation
  • SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, 2021, Journal of Clinical Investigation

Best Publications

  • Hemoglobin metabolism in the malaria parasite Plasmodium falciparum.

    Susan E. Francis;David J. Sullivan;Daniel E. Goldberg

  • New uses for old drugs

    Curtis R. Chong;David J. Sullivan

  • Deployment of convalescent plasma for the prevention and treatment of COVID-19.

    Evan M. Bloch;Shmuel Shoham;Arturo Casadevall;Bruce S. Sachais

  • On the molecular mechanism of chloroquine's antimalarial action.

    David J. Sullivan;Ilya Y. Gluzman;David G. Russell;Daniel E. Goldberg

  • Chemical genetics of Plasmodium falciparum.

    W. Armand Guiguemde;Anang A. Shelat;David Bouck;Sandra Duffy

  • Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins

    David J. Sullivan;Ilya Y. Gluzman;Daniel E. Goldberg

  • Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.

    Wesley C. Van Voorhis;John H. Adams;Roberto Adelfio;Roberto Adelfio;Vida Ahyong

  • A clinical drug library screen identifies astemizole as an antimalarial agent

    Curtis R Chong;Xiaochun Chen;Lirong Shi;Jun O Liu

  • Theories on malarial pigment formation and quinoline action.

    David J Sullivan

  • A common mechanism for blockade of heme polymerization by antimalarial quinolines

    David J. Sullivan;Hugues Matile;Robert G. Ridley;Daniel E. Goldberg

  • Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma

    Jiangbing Zhou;Toral R. Patel;Rachael W. Sirianni;Garth Strohbehn

  • Host mediated regulation of superinfection in malaria

    Silvia Portugal;Céline Carret;Mario Recker;Andrew E Armitage

  • The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization.

    John M. Pisciotta;Isabelle Coppens;Abhai K. Tripathi;Peter F. Scholl

  • SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.

    Hassen Kared;Andrew D. Redd;Evan M. Bloch;Tania S. Bonny

  • Inhibition of angiogenesis by the antifungal drug itraconazole.

    Curtis R. Chong;Jing Xu;Jun Lu;Shridhar Bhat

  • A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells.

    Marion Avril;Abhai K. Tripathi;Andrew J. Brazier;Cheryl Andisi

  • Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.

    Kate Poropatich;David J. Sullivan

  • The shape and size of hemozoin crystals distinguishes diverse Plasmodium species

    Gregory S Noland;Noelle Briones;David J Sullivan

  • Platelet Factor 4 Mediates Inflammation in Experimental Cerebral Malaria

    Kalyan Srivastava;Ian A. Cockburn;Anne Marie Swaim;Laura E. Thompson

  • Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and β-hematin

    Mary M. Chen;Lirong Shi;David J. Sullivan

Frequent Co-Authors

Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Aaron A.R. Tobian
Aaron A.R. Tobian Johns Hopkins University School of Medicine
Andrew Pekosz
Andrew Pekosz Johns Hopkins University
Arturo Casadevall
Arturo Casadevall Johns Hopkins University
Jun O. Liu
Jun O. Liu Johns Hopkins University School of Medicine
Gary H. Posner
Gary H. Posner Johns Hopkins University
Daniel E. Goldberg
Daniel E. Goldberg Washington University in St. Louis
Nirbhay Kumar
Nirbhay Kumar George Washington University
David A. Sack
David A. Sack Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing David J. Sullivan

Trending Scientists